Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Mastercard

Synchrony Financial

The drugstore chain is looking for growth opportunities as consumers shop more online and competitors take some of its business.

Walgreens looks to credit card, financial services to drive loyalty and boost revenue

AvalonBay Communities

Annaly Capital

AT&T

If the new administration is successful in passing $2,000 stimulus payouts, these income stocks could line your pockets for a long time to come.

The Best High-Yield Dividend Stocks to Buy With a $2,000 Stimulus Check

DEERFIELD, Ill. & JOHNSON CITY, N.Y.--(BUSINESS WIRE)--Walgreens Boots Alliance and iA announced that WBA has made a majority investment in iA to advance automation capabilities for the pharmacy industry.

Walgreens Boots Alliance Makes a Majority Investment into iA to Advance Automation Capabilities for the Pharmacy Industry

First of Long Island

Telephone and Data Systems

Dividend Champions, or dividend aristocrats, are great dividend stocks because they've raised dividends for at least 25 consecutive years. The post 3 Dividend Champions for Yield and Total Returns appeared first on InvestorPlace.

3 Dividend Champions for Yield and Total Returns

Amgen

Cisco Systems

Chevron

Dow Inc

Coca-Cola

Microsoft

Tesla

Vanguard Energy ETF

Data indicates The Dogs of the Dow outperform over long time frames. I contend the Dogs provide a good risk/reward profile for Dividend Growth investors.

The Dogs Of The Dow: My Plan To Improve On The Market Beating Strategy

Shares of pharmacy retailer Walgreens Boots Alliance Inc (NASDAQ: WBA) ended 2020 lower by nearly 30%, but Baird sees several catalysts for the company that it said should put an end to years of "train wreck" performance. The Walgreens Analyst: Eric Coldwell upgraded Walgreens from Neutral to Outperform with a price target lifted from $41 to $55.

Baird Upgrades Walgreens Boots, Expects Turnaround Of 'Train Wreck' Performance

D.R. Horton

FedEx

General Motors

JPMorgan Chase & Co

Prudential Financial

Here are seven cheap stocks with solid businesses that may power portfolios in 2021 The post The 7 Best Cheap Stocks to Kick Off 2021 appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets

The 7 Best Cheap Stocks to Kick Off 2021

CVS Health

Rite Aid

The three drugstore chains have expanded their digital offerings and stepped up their focus on health and wellness to keep up with consumer preferences.

Covid vaccinations offer CVS, Walgreens and Rite Aid a chance to showcase how drugstores have changed

Merck

Verizon

For income investors, dividend strategies don't come any easier than the “Dogs of the Dow.”

Dogs Of The Dow 2021: Buy, Hold Or Sell These 10 Dividends?

Yamana Gold

Exelixis

Teva Pharmaceutical

Wells Fargo

Bargains are plentiful for value investors in the new year.

5 Value Stocks That Will Make You Richer in 2021

COVID-19 didn't give Walgreens Boots Alliance the windfall you might think in 2020.

Why Shares of Walgreens Boots Alliance Dropped 29.4% in 2020

Advanced Micro Devices

Dollar General

Procter & Gamble

Simply Good Foods

Constellation Brands

T-Mobile US

As 2021 starts, long-term investments may look a little shaky, which could make now an ideal time to look for short-term stocks to buy. The post 7 Short-Term Stocks to Move Quickly On appeared first on InvestorPlace.

7 Short-Term Stocks to Move Quickly On

Canadian Solar

JetBlue Airways

Landbridge Co LLC

Peloton

Acacia Communications

Bed Bath & Beyond

First Solar

Newell Brands

At about halfway through the trading day on Friday, the broad markets were trading sideways, with the exception of the Nasdaq, which was fairly positive.

Canadian Solar, JetBlue, L Brands, Peloton, Tesla and More Friday Afternoon Analyst Calls

Garmin

Elanco Animal Health Inc

Bitcoin, Walgreens, Elanco Animal Health and Garmin were our top stock trades for Thursday. Let's have a look at what the charts are saying.

4 Top Stock Trades for Friday: Bitcoin, WBA, ELAN, GRMN

Walgreens reported revenue growth and a smaller-than-expected earnings decline, and an analyst is worried about Coca-Cola's tax problems.

Dow Jones Soars Despite Riots; Walgreens Stock Surges on Strong Earnings; Coca-Cola Downgraded Again

Enterprise Products Partners

Fiverr

IZEA

Lockheed Martin

OncoCyte

Osisko Gold Royalties

Disney

Which of our experts will win the best stocks contest? They're all betting on themes likely to dominate in 2021 and beyond.

10 Best Stocks For 2021: After An Unprecedented Year, What's Next?

Walgreens Boots Alliance Inc. (NASDAQ: WBA) said on Thursday that its earnings and revenue came in better than expected in the fiscal first quarter. The company attributed its hawkish quarterly performance to robust pharmacy sales in recent months.

Walgreens says pharmacy sales remained strong in the fiscal first quarter

Walgreens Boots Alliance, Inc. (WBA) CEO Stefano Pessina on Q1 2021 Results - Earnings Call Transcript

We previously highlighted WBA as a swing trade, and now see shares breaking out. The company is delivering results in its cost management strategies.

Walgreens: Breaking Out

The pharmacy giant turned in a better-than-expected performance in Q1 despite COVID-19 headwinds.

How Walgreens Boots Alliance Beat Expectations in Q1

Pfizer

Exxon Mobil

This not-so-old strategy of identifying undervalued blue chip stocks has had its moments -- but not enough of them.

The Dogs of the Dow Didn't Hunt in 2020, and 2021 Isn't Looking Much Better

Walgreens Boots Alliance, Inc. reported on Thursday (Jan. 7) as part of its Q1 fiscal 2021 results that its Retail Pharmacy USA division had $27.2 billion in sales, marking a 3.9 percent rise from the year-ago quarter, including the effect of "store optimization programs" unveiled in the past, according to an announcement. Sales in comparable stores […]

Walgreens Retail Pharmacy USA Reports $27.2 Billion In Sales

News for Walgreens Stock (WBA)